Single User License
INR 199976
Site License
INR 399952
Corporate User License
INR 599928

Service Tax Additional

select a format

Single User License
USD 2995
Site License
USD 5990
Corporate User License
USD 8985


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"

BIOSIMILARS-Regulatory Framework and Pipeline Analysis

BIOSIMILARS-Regulatory Framework and Pipeline Analysis

  Request for Sample Report

Executive Summary

BIOSIMILARS-Regulatory Framework and Pipeline Analysis Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will reduce the healthcare spending substantially. All the countries are focusing on reducing the healthcare expenditure and biosimilars compliments to this goal. Biologic products are complex in structure and follow a complex manufacturing process thus, some variation exists between the reference product and its biosimilar. It is very important to assess the variations in biosimilars by comparing with reference product to ensure quality, non-clinical, and clinical properties, which has given rise to the regulatory requirements for biosimilars. Regulatory requirement for approving biosimilars varies across different regulatory bodies. However, all the countries have derived the basic theme from EMA and WHO guidelines for framing their regulatory structure. There is a need to harmonize the nomenclature of biosimilars, extrapolation of indications, and interchangeability of biosimilars with reference products across the regulatory bodies. Biosimilars market is developing and it could be well established with the pipeline that is poised to deliver a wave of biosimilars in the market in the near future Scope The scope of the report includes Introduction Market dynamics: Trends, Drivers, and Barriers WHO guidance for biosimilars Regulatory overview, biosimilar guidelines, regulatory framework for biosimilars, and market outlook for: Europe, USA, India, South Korea, Japan and China. Key players Pipeline Analysis Overview By Stage of Development / Molecule / Therapy Area / Indication Late-Stage / Phase II / Phase I Pipeline Biosimilars Reasons To Buy The report will enhance your decision-making capability by allowing you to Understand the regulatory requirement and regulatory framework that facilitates effective product development strategy as biosimilars industry is currently highly focused, growing, and outpacing the growth rate of small molecule pharmaceutical market Targeting geographies would be easy by comparing different regulatory frameworks; this would also provide a base for designing a strategy to enter the developed markets. Biosimilars are of interest in developed countries to reduce the healthcare expenditure With the recent approvals of biosimilars by USFDA, the biosimilars market is going to grow and this report examines the post approval market landscape Examine the biosimilars pipeline and specifies the products that are highly targeted, it also includes analysis of highly focused indications, mechanism of actions, and therapy areas in the pipeline Analyze the details of the clinical pipeline that includes late stage products, Phase II, and Phase I products. Detailed understanding of the pipeline will help in targeting the products for development, rate the current products and predict the competition

Executive Summary Introduction Biosimilars Industry Dynamics Trends Drivers Restraints Biosimilars Regulation: WHO's Guidance Biosimilars in Europe Overview Regulatory Framework Market Outlook Biosimilars in the US Overview Regulatory Framework Market Outlook Biosimilars in India Overview Regulatory Framework Market Outlook Biosimilars in South Korea Overview Regulatory Framework Market Outlook Biosimilars in Japan Overview Regulatory Framework Market Outlook Biosimilars in China Overview Regulatory Framework Market Outlook Key Market Players Biosimilars Pipeline Analysis Overview By Stage of Development By Molecule By Therapy Area By Indication By MoA/RoA Late-Stage Pipeline Biosimilars Phase II Pipeline Biosimilars Phase I Pipeline Biosimilars

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]